Potential antidiabetics. XII. N- 1 -phenylcarbamoyl-4-arylazo(3- and-or 5-substituted) pyrazoles and their biological activities.
D000818:Animals; D001391:Azo Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D001786:Blood Glucose; D002219:Carbamates / Q000138:chemical synthesis* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D007259:Infrared Rays; D051379:Mice; D011720:Pyrazoles / Q000138:chemical synthesis* / Q000627:therapeutic use; D013057:Spectrum Analysis; D013329:Structure-Activity Relationship
D001391:Azo Compounds; D001786:Blood Glucose; D002219:Carbamates; D007004:Hypoglycemic Agents; D011720:Pyrazoles